<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04867967</url>
  </required_header>
  <id_info>
    <org_study_id>17-7925 BO</org_study_id>
    <nct_id>NCT04867967</nct_id>
  </id_info>
  <brief_title>Yoga and MBSR for TTH</brief_title>
  <official_title>Yoga and Mindfulnes-based-stress-reduction for Patients With Tension-type Headache</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universität Duisburg-Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eden Stiftung</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universität Duisburg-Essen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary study objectives&#xD;
&#xD;
        1. evaluate the short-term effect of yoga intervention in addition to routine care on&#xD;
           headache frequency in patients with frequent or chronic tension-type headache compared&#xD;
           to routine care alone (waiting group).&#xD;
&#xD;
        2. to evaluate the short-term effect of yoga intervention in addition to routine care on&#xD;
           headache frequency in patients with frequent episodic or chronic tension-type headache&#xD;
           compared with stress management through mindfulness-based stress reduction (MBSR) in&#xD;
           addition to routine care.&#xD;
&#xD;
      Secondary study objectives&#xD;
&#xD;
      Evaluation of the medium-term effect of the intervention on headache frequency as well as the&#xD;
      short- and medium-term effect on the secondary target parameters in comparison to the waiting&#xD;
      group and MBSR. Further evaluation of the safety and acceptability of the intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Headache Frequency</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Headache Frequency self-reported by a headache diary</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Headache Frequency</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Headache Frequency self-reported by a headache diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of headache episodes</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Duration of headache episodes self-reported by a headache diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of headache episodes</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Duration of headache episodes self-reported by a headache diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Numeric rating scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Numeric rating scale (NRS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain medication use</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Pain medication use self-reported by a headache diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain medication use</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Pain medication use self-reported by a headache diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache related disability</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Headche Impact Test 6 (HIT-6)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Headache related disability</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Headche Impact Test 6 (HIT-6)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>SF-36 questionaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related quality of life</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>SF-36 questionaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Depression and Anxiety scale (DAAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Depression and Anxiety scale (DAAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Depression and Anxiety scale (DAAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Depression and Anxiety scale (DAAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain catastrophizing</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Pain catastrophizing scale (PCS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain catastrophizing</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Pain catastrophizing scale (PCS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain acceptance</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Chronic pain acceptance questionaire (CPAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain acceptance</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Chronic pain acceptance questionaire (CPAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mindfulness</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Mindfulness Attention and Awerness scale (MAAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mindfulness</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Mindfulness Attention and Awerness scale (MAAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Awareness</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Body Awareness questionaire (BAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Awareness</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Body Awareness questionaire (BAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>post-intervention (8 weeks)</time_frame>
    <description>Adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>follow-up (20 weeks)</time_frame>
    <description>Adverse events</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Tension-Type Headache</condition>
  <arm_group>
    <arm_group_label>Iyengar Yoga Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8-week yoga class; once weekly; 90 minutes&#xD;
Note: First administered face-to-face, due to Covid-restrictions changed to online classes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindfulness-based stress reduction</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8-week MBSR class; once weekly; 90 minutes&#xD;
Note: First administered face-to-face, due to Covid-restrictions changed to online classes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Waitlist control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Waitlist control, ususal care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Iyengar Yoga</intervention_name>
    <description>Classical Iyengar Yoga intervention, especially designed for headache patients. Note: First administered face-to-face, due to Covid-restrictions changed to online classes</description>
    <arm_group_label>Iyengar Yoga Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-based stress reduction</intervention_name>
    <description>Standardazied Mindfulness-based stress reduction intervention Note: First administered face-to-face, due to Covid-restrictions changed to online classes</description>
    <arm_group_label>Mindfulness-based stress reduction</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  episodic or chronic tension-type headache according to ICHD-3 definition&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  medication induced headache according to ICHD-3 definition&#xD;
&#xD;
          -  Cluster-headache according to ICHD-3 definition&#xD;
&#xD;
          -  serious chronic systemic or acute physical or mental illness&#xD;
&#xD;
          -  Dementia&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  actual in a yoga or MBSR class&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustav Dobos, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Duisburg-Essen, Faculty of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dennis Anheyer, MA &amp; BSc</last_name>
    <phone>+4920117425550</phone>
    <email>d.anheyer@kem-med.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Holger Cramer, PhD</last_name>
    <email>h.cramer@kem-med.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Evang. Kliniken Essen-Mitte</name>
      <address>
        <city>Essen</city>
        <state>Northrhine-Westphalia</state>
        <zip>45276</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dennis Anheyer, MA &amp; BSc</last_name>
      <phone>+4920117425550</phone>
      <email>d.anheyer@kem-med.com</email>
    </contact>
    <contact_backup>
      <last_name>Holger Cramer, PhD</last_name>
      <email>h.cramer@kem-med.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 29, 2021</study_first_submitted>
  <study_first_submitted_qc>April 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2021</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universität Duisburg-Essen</investigator_affiliation>
    <investigator_full_name>Holger Cramer</investigator_full_name>
    <investigator_title>PD Dr. rer. medic</investigator_title>
  </responsible_party>
  <keyword>Tension-Type Headache</keyword>
  <keyword>Yoga</keyword>
  <keyword>Mindfulness-based stress reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tension-Type Headache</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

